ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

A HER2-targeted Antibody-Drug Conjugate, RC48-ADC, Exerted Promising Antitumor Efficacy and Safety with Intravesical Instillation in Preclinical Models of Bladder Cancer.

Xuwei Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.